For the latest COVID-19 information for Massey, visit


News Center

Latest News

Prevention & Control

Massey researchers find that failure to expand ACA Medicaid coverage would widen disparities in screening uninsured and low-income women for breast and cervical cancer

May 04, 2015


Virginia Commonwealth University Massey Cancer Center researchers recently conducted a study that found low-income and uninsured women in states that are not expanding their Affordable Care Act (ACA) Medicaid coverage are less likely to receive breast and cervical cancer screenings compared to states that are implementing expansions.

The ACA is allowing states to extend their Medicaid health insurance coverage for non-elderly adults with an annual income up to 133 percent of the federal poverty line. However, only approximately half of the states are expanding their Medicaid eligibility.

“I was interested in what the Medicaid expansion means in socioeconomic terms,” said Lindsay Sabik, Ph.D., a member of the Cancer Prevention and Control research program at Massey and the study’s lead author.

The findings were published in the American Journal of Preventive Medicine and highlighted in the Journal of the American Medical Association. In the study, Sabik and colleagues Cathy Bradley, Ph.D., and Wafa Tarazi looked at the potential impact of the ACA on women’s cancer screenings for low-income and uninsured populations in the states implementing expansion and the states that are not. Bradley is associate director for cancer prevention and control and Theresa A. Thomas Memorial Foundation Endowed Chair in Cancer Prevention and Control at Massey and chair of the VCU Department of Healthcare Policy and Research. Tarazi is a doctoral candidate and graduate research assistant at the VCU School of Medicine.

Using pre-ACA, self-reported data from the 2012 Behavioral Risk Factor Surveillance System (BRFSS), the team analyzed differences of income, race and ethnicity for women ages 52-64 years who followed U.S. Preventive Services Task Force guidelines and underwent a mammogram within two years, and women ages 24-64 years who followed the task force’s recommendations and had Pap tests performed within three years. The BRSS is a telephone survey conducted in all 50 states by the U.S. Centers for Disease Control to collect public health data.

The researchers found that women who do not have health insurance are significantly less likely to get regular mammograms and Pap tests. The study results suggest that uninsured women in non-expansion states are less likely to receive potentially lifesaving breast and cervical cancer screenings by 7.9 percent and 4.9 percent, respectively.

Sabik points out that as Medicaid coverage expands and women in nonexpansion states, who are more likely to be low-income and African American than in expansion states, continue to lack health insurance coverage, the disparities in breast and cervical cancer screenings may continue to widen. She advises that nonexpansion states should pay attention to existing disparities in preventative care across populations. She suggests that officials consider the costs and benefits of Medicaid expansion for these groups and whether the expansion might narrow the gap in coverage for potentially life-saving breast and cervical screenings.

“There’s a lot that still needs to be done to make the Medicaid program more consistent across states to give all women fair access to cancer screenings,” added Sabik, who is also an assistant professor of healthcare policy and research at the VCU School of Medicine.

Sabik is currently working on a National Cancer Institute (NCI)-funded Medicaid policy research study about breast and cervical cancer screenings for low-income women. In that study, she is looking into Medicaid administrative data as well as cancer registry data across states to determine how Medicaid impacts these screenings for low-income women and to determine any racial and ethnic differences in treatment.

This study was supported by a National Institutes of Health grant No. R01CA178980, co-funded by the National Cancer Institute and the Office of Behavioral and Social Sciences Research, and, in part, by VCU Massey Cancer Center’s NIH-NCI Cancer Center Support Grant P30 CA016059.

The full manuscript of this study is available online at:

Written by: Massey Communications Office

Related News

Center News & Funding, Clinical, Prevention & Control

Massey specialists awarded $5 million to enhance lung cancer screening and treatment for veterans

Get access to new, innovative care

Get access to new, innovative care

Treatments in clinical trials may be more effective or have fewer side effects than the treatments that are currently available. With more than 200 studies for multiple types of cancers and cancer prevention, Massey supports a wide array of clinical trials.

Search clinical trials
Find a provider

Find a provider

Massey supports hundreds of top cancer specialists serving the needs of our patients. Massey’s medical team provides a wealth of expertise in cancer diagnosis, treatment, prevention and symptom management.

Find a provider